Trials / Completed
CompletedNCT04525547
Safety and Effectiveness of Nintedanib in Korean Patients
A Regulatory Required Non-interventional Study to Monitor the Safety and Effectiveness of Ofev(Nintedanib 150mg/100mg BID) in Korean Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to monitor the safety and effectiveness of Ofev in Korean patients in a routine clinical practice setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nintedanib | Nintedanib |
Timeline
- Start date
- 2021-01-13
- Primary completion
- 2022-08-02
- Completion
- 2022-08-18
- First posted
- 2020-08-25
- Last updated
- 2024-03-12
- Results posted
- 2024-03-12
Locations
22 sites across 1 country: South Korea
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04525547. Inclusion in this directory is not an endorsement.